RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
117 hedge funds and large institutions have $494M invested in Rubius Therapeutics, Inc in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
43% less capital invested
Capital invested by funds: $863M → $494M (-$369M)
Holders
117
Holding in Top 10
3
Calls
$4.78M
Puts
$556K
Top Buyers
| 1 | +$2.7M | |
| 2 | +$2.58M | |
| 3 | +$2.49M | |
| 4 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
+$1.65M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.25M |
Top Sellers
| 1 | -$6.48M | |
| 2 | -$5.05M | |
| 3 | -$1.16M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$607K |
| 5 |
Citigroup
New York
|
-$578K |